Healthcare Realty (HR) Q1 2026 Earnings Transcript

DATE

May 1, 2026 at 9:00 a.m. ET

CALL PARTICIPANTS

• Chief Executive Officer — Peter Scott
• Chief Operating Officer — Robert Hull
• Chief Financial Officer — Daniel Gabbay
• Chief Investment Officer — Ryan Crowley

Need a quote from a Motley Fool analyst? Email [email protected]

TAKEAWAYS

• Leasing Activity — Over 2 million square feet of leases signed, setting an all-time company record.
• Same-Store NOI Growth — 6.9%, representing the highest quarterly increase in company history.
• Normalized FFO Per Share — $0.41, up sequentially from $0.40 in the previous quarter.
• Same-Store Occupancy — 92.3%, an increase of 110 basis points year over year.
• Total Portfolio Occupancy — 90.5% reported, cited as a key short-term earnings driver.
• Tenant Retention Rate — 93.5% achieved in the quarter, supported by early renewals across the portfolio.
• Cash Leasing Spread — 4.2% on executed leases; 25% of leases posted spreads above 5%.
• Annual Lease Escalators — Average of 3.1% for new and renewal leases this quarter.
• Weighted Average Lease Term — Nearly 8 years across the portfolio.
• Stock Buybacks — $100 million repurchased year-to-date; $400 million remains under current authorization.
• Joint Venture Activity — $18 million pro rata invested in acquisitions through joint ventures; JV NOI now comprises 5% of total portfolio NOI.
• Redevelopment Progress — Two new projects added, with one Boston project 100% pre-leased and another in Charlotte 98% leased; redevelopment portfolio is 64% pre-leased overall.
• Capital Allocation — $50 million in stock repurchased in March amid market dislocation; $25 million invested in redevelopment.
• New Term Loan Facility — $400 million unsecured delayed-draw term loan fully committed, with expected all-in pricing of 4.8%.
• Dividend Payout Ratio — 75%, with FAD per share at $0.32.
• Guidance Raised — Full-year normalized FFO per share increased to a range of $1.59 to $1.65; same-store cash NOI growth guidance raised by 25 basis points to 3.75%-4.75%.

SUMMARY

Healthcare Realty Trust (HR +2.41%) reported record-setting quarterly leasing activity, with management attributing performance to an overhauled operating platform and strategic capital allocation. The company executed two new redevelopment projects, including a fully leased medical office building in Boston and a near-complete project in Charlotte, targeting significant NOI contributions over its three-year plan. Incremental use of joint ventures was positioned as a scalable component of external growth, with the company highlighting its current 5% NOI exposure through these structures. The board refresh process was advanced with the announced retirement of a long-serving director, planning for new expertise and diversity on the board by year-end. Financing initiatives included finalizing a $400 million delayed-draw term loan at pricing materially below the company’s 2026 cost of debt assumptions, providing flexibility to address near-term maturities and maintain targeted leverage.

• Management stated, “We are raising both FFO and same-store guidance early in the year,” underscoring stronger-than-expected operational results and outlook.
• “Escalators will be the primary driver of core earnings growth going forward,” anchoring the company’s expected 5%+ organic earnings trajectory in 2026, excluding impacts from portfolio optimization and deleveraging.
• Healthcare system relationships drove new and renewal leasing activity, with specific large deals secured in Atlanta, Charlotte, Upstate New York, and Charleston contributing to the weighted average lease term increase.
• The current redevelopment pipeline represents a potential $50 million in NOI upside over three years, with the company stating redevelopments deliver a 10% cash-on-cash yield from a combination of occupancy and rental rate increases.
• Delayed-draw term loan proceeds will be used to refinance $600 million in bond maturities, while leaving approximately $1 billion of remaining line of credit liquidity for additional capital market flexibility.

INDUSTRY GLOSSARY

• NOI (Net Operating Income): Rental and related income generated by real estate assets after operating expenses, but before interest and depreciation, used as a measure of property-level profitability.
• Cash Leasing Spread: The difference in rental rates between new or renewed leases and expiring leases, measured on a cash basis and expressed as a percentage.
• SNO (Signed Not Occupied): Square footage under executed leases where tenants have not yet commenced occupancy, serving as a forward indicator of future occupancy and earnings.
• FAD (Funds Available for Distribution): Cash-based REIT metric representing residual cash flow available to pay dividends after maintenance capital expenditures and leasing costs.

Full Conference Call Transcript

Peter Scott: Thanks, Ron. Joining me on the call today are Rob Hull, our COO; and Dan Gabbay, our CFO. Also available for the Q&A portion of the call is Ryan Crowley, our CIO. It has been just over a year since I assumed the CEO role, and we have made significant progress in that short period of time. In many ways, we entered 2026 as an entirely new company. We added industry expertise to our revamped and more financially rigorous operating platform, we refined our portfolio, and we rightsized our balance sheet. All of this was in preparation to meet or exceed our 3-year earnings forecast.

I am pleased to report the hard work and immense preparation is manifesting into better results. While 1 quarter does not guarantee a 3-year earnings forecast, it does create a solid foundation for outperformance while sustaining the winning mentality we have worked hard to instill at Healthcare Realty 2.0. Now let’s turn to our results for the first quarter. Every day we are executing with purpose and intensity. We signed over 2 million square feet of leases an all-time high. We reported same-store NOI growth of nearly 7%, also an all-time high. We accretively bought back more stock. We completed our first joint venture acquisition. We continue to stabilize our redevelopment portfolio.

And our capital markets plan is beginning to take shape. The net impact of all this, our first quarter results were far better than expectations. We are raising both FFO and same-store guidance early in the year. And there is more to come on the horizon with a strong leasing pipeline. I wanted to elaborate more on the earnings growth framework for Healthcare Realty 2.0. Earnings growth has unequivocally become the dominant metric that determines a premium multiple in the REIT industry. If you go into any AI platform and search medical office characteristics, you will note the typical catchphrases that have become synonymous with sector: stable cash flow, recession-resistant, Steady Eddie, and 2% to 3% growth.

In a low interest rate environment, like we experienced from 2010 to 2020 when the 10-year treasury averaged low 2%, this all sounded great. Investors were able to generate alpha in medical office with very little risk. However, with the 10-year treasury at 4.3% today and our stock trading at an 11x FFO multiple, this simply won’t cut it anymore. We see 2 challenges in front of us: put up better numbers, which we are doing, and break down these historical stereotypes. As the only public REIT focused exclusively on outpatient medical, we will be the trailblazer and redefine what success means in our sector. So let me walk you through the main pillars of organic growth. First, occupancy.

Sector-wide occupancy is approaching 93% because of strong demand and limited supply growth. We see multiple years of sustained tailwinds in front of us driven by the rapid growth of the 65-plus population and the unabated shift in care to outpatient settings. At HR 2.0, our same-store occupancy improved this quarter to 92.3%, a year-over-year increase of 110 basis points. Total occupancy has improved to 90.5% and is a significant near-term earnings growth driver as we stabilize our lease-up and redevelopment portfolio. Second, annual escalators. Under the new asset management platform, our average annual escalator on signed leases is 3% plus. I cannot overemphasize the importance of the annual escalator on earnings growth.

With our portfolio NOI at approximately $650 million, escalators will be the primary driver of core earnings growth going forward. Third, retention rate. Often overlooked, retention rate is a critical driver of earnings growth. Downtime and capital expenditures, which are the silent killer of earnings growth, are significantly lower for renewal lease deals compared to new lease deals. Therefore, the higher the retention rate, the less capital we have to commit, the higher the lease IRR, the more profitable the deal is to us. During the first quarter, our retention rate was 93.5%. Fourth, cash leasing spreads.

With our portfolio optimization complete and our concentration of assets in higher growth markets, including the Sunbelt market, I would anticipate our cash leasing spreads improving. In the first quarter, our cash leasing spread was 4.2%. Importantly, 1 out of every 4 leases we signed had a cash leasing spread greater than 5%. When you add all this up, occupancy growth, annual escalators, higher retention and improved cash leasing spreads, we expect to generate materially higher earnings growth going forward. Our same-store results this quarter are a good indicator that we are heading in the right direction.

And as a reminder, our core earnings growth in 2026 is tracking above 5% excluding the impact from the necessary portfolio optimization and deleveraging. I wanted to spend a moment on external growth and capital allocation, which are incremental to our organic pillars of growth. As we recently disclosed, our capital allocation approach will remain incredibly disciplined. During the first quarter, we did exactly what we said we would do. We bought back $100 million of stock, we completed in excess of $20 million of acquisitions and we invested $25 million in our redevelopment portfolio. Let me provide a little more context behind our priorities. First, stock buybacks.

If we experience dislocation in our stock price, we will not hesitate to acquire shares. This provides us with significant and immediate accretion. We have $400 million of stock buyback capacity remaining under our current authorization. Second, acquisition. All external acquisitions will be done in joint ventures. Joint ventures currently encompass 5% of our total NOI, so there is ample room for this to grow. We would expect initial cash yields of greater than 7%, which exceeds our implied cap rate. In terms of magnitude, I could see us accretively allocating $50 million to $100 million of capital into our KKR joint venture in 2026. Third, redevelopment, which currently consists of 23 properties that are 64% pre-leased.

Redevelopments are the primary source of the $50 million of NOI upside in our 3-year forecast, and we continue to track ahead of schedule. I would expect the number of assets in redevelopment to modestly tick up in the coming quarters as we front-load our spend into the earlier part of our 3-year plan. This will allow us to maximize the NOI upside opportunity sooner. As a reminder, our average cash-on-cash yield for the redevelopment portfolio is 10% and comes through a combination of increased occupancy and/or increased rental rate. Importantly, none of these priorities, buybacks, joint venture acquisitions and redevelopments, are mutually exclusive.

In addition, while not part of our guidance, we are open to selling more assets, including core assets, and accretively recycling the proceeds into any one of our priorities to further improve earnings growth. Finishing now with a quick note on our Board. As part of our ongoing Board refreshment initiatives, longtime Director, Jay Leupp announced he will retire after our upcoming annual meeting. I would like to provide a sincere thanks to Jay for his contributions to the organization over the years. Upon Jay’s departure, the average tenure of our remaining directors is less than 2 years. We plan to add a new director later this year, to more prioritize that person’s experience and diversity.

With that, let me turn the call over to Rob.

Robert Hull: Thanks, Pete. The first quarter was the company’s strongest ever for leasing. Our team executed over 290 leases, representing more than 2 million square feet. Lease economics across both new and renewal leases continued to improve. Annual escalators averaged 3.1% and the weighted average lease term was nearly 8 years, bolstering the portfolio’s long-term growth profile. Tenant retention was 93.5%, driven by a number of early renewals across the portfolio. Included are 8 single tenant renewals totaling nearly 740,000 square feet, for an average extension of approximately 10 years. This meaningfully reduces our lease maturities through the end of 2027. And cash leasing spreads were strong, averaging 4.2%. Demand for medical outpatient buildings remains robust.

We continue to see favorable sector fundamentals as absorption outstripped completions during the quarter and rental rates continued to climb. Health systems are seeing steady operating trends and investing in higher-margin outpatient services. These favorable industry fundamentals are translating into better performance for our portfolio. Health system relationships remain a key area of focus as their demand for space continues to grow, improving the credit profile of our portfolio. This quarter, we saw a substantial health system activity, including, in Atlanta, 176,000 square feet of new and renewal leases with Wellstar across 6 on-campus buildings, including a 59,000 square foot cancer center. The renewals carry an average term of 5 years with a blended cash leasing spread of approximately 4%.

Wellstar is a leading health system in the Atlanta MSA with an A+ credit rating. In Charlotte, 6 renewal leases totaling 154,000 square feet with Advocate Health. The average term was more than 7 years with a blended cash leasing spread over 5%. Advocate Health is the leading health system in Charlotte with well over 50% market share and carries a AA credit rating. In Upstate New York, we leased 64,000 square feet of clinical and surgery center space to Trinity Health St. Peter’s Hospital. The leases have an average term of nearly 6.5 years and annual escalators of 3%. Trinity Health is a top 10 health system nationally with a AA- credit rating.

And in Charleston, 3 lease renewals for 55,000 square feet with MUSC Health, maintaining 100% occupancy across 2 buildings. The leases have an average term of 9 years with an average cash leasing spread of nearly 14%. MUSC is South Carolina’s only comprehensive academic health system with 16 hospitals and regional medical centers. Looking ahead, occupancy gains over the remainder of the year will be driven by a robust new leasing pipeline of approximately 1.4 million square feet, strong tenant retention and our 490,000 square foot Signed Not Occupied or SNO pipeline. Turning to redevelopment. We saw a gain of 900 basis points sequentially in the lease percentage of our redevelopment portfolio.

This quarter, we added 2 new projects, including a $25 million redevelopment of a 155,000 square foot MOB connected to Tufts Medical Center in Boston. The building is 100% pre-leased with a 10-year term and 3% annual escalators. We also completed a $35 million 2 MOB project located in Charlotte, adjacent to Novant Health Huntersville Medical Center. The redevelopment is 98% leased with a stabilized yield within our targeted range of 9% to 12%. The 2 buildings will move into same store once a full calendar year has passed since completion. Our results this quarter demonstrate the team’s ability to drive accretive lease economics and strengthen our health system relationships.

We are well positioned to build on this momentum through the balance of the year and deliver strong NOI growth to our shareholders. Now I will turn it over to Dan to discuss our financial results.

Daniel Gabbay: Thanks, Rob. 2026 is off to a great start. We reported normalized FFO per share of $0.41, up sequentially from $0.40, and we achieved same-store cash NOI growth of 6.9%. Additionally, FAD per share was $0.32, resulting in a quarterly dividend payout ratio of 75%. Our outperformance this quarter was driven by 110 basis points of year-over-year same-store occupancy gains, 4.2% cash leasing spreads and our improved balance sheet. Q1 same-store occupancy finished at 92.3% and same-store margins expanded 60 basis points year-over-year. Notably, 95% of our total NOI is included in our same-store pool. Turning to capital allocation. As Pete mentioned, Q1 was active across all our strategic priorities.

In March, we opportunistically repurchased an additional $50 million of shares as global conflicts pushed the stock market into correction territory. This brings our total repurchases year-to-date to $100 million or 5.7 million shares at a weighted average price of $17.38. And at quarter-end, we closed on a JV acquisition for $18 million at our pro rata share, and commenced 2 new redevelopments with an expected cost of $31 million. We remain confident in our ability to continue allocating capital towards accretive redevelopments and selective external growth while maintaining our year-end leverage target in the mid-5x area. I would like to call out a couple of items related to our balance sheet.

First, we are putting in place a new $400 million unsecured delayed draw term loan. Our strong bank partnerships allowed us to move quickly during a period of heightened volatility. The facility is fully committed and expected to close in May. Drawn pricing is at SOFR plus 90 basis points and all-in pricing inclusive of transaction costs is approximately 4.8%. This is inside our 5% cost of debt assumption for 2026. We plan to draw the term loan in late July to repay our $600 million bond maturity, with the balance funded on our line of credit.

Factoring in this transaction, we would still have $1 billion of remaining liquidity on our line which provides meaningful flexibility as we consider all of our future capital markets alternatives. As discussed last quarter, we also launched our commercial paper program. We currently have roughly $250 million outstanding, which is fully backstopped by our line of credit. Borrowing costs today are approximately 40 to 50 basis points lower than our line. Finally, during the quarter, we also extended the maturities on $400 million of swaps associated with our existing unsecured term loans, locking in SOFR at 3.3% through debt maturity in 2029. These levels remain attractive as expectations for Fed cuts diminished during the quarter.

Turning to 2026 guidance, which you can find on Page 11 of our Q1 supplemental report, we increased full year normalized FFO per share guidance by $0.01 to $1.59 to $1.65 per share or $1.62 at the midpoint. And we increased same-store cash NOI growth by 25 basis points to a revised range of 3.75% to 4.75%. These results are driven by strong leasing outcomes and 4% plus cash re-leasing spreads in our same-store portfolio. Uses of capital increased $75 million for the year to reflect the incremental share repurchases and acquisitions in Q1 that we discussed earlier. Our guidance does not include any additional acquisitions, redevelopments or incremental share repurchases for the remainder of the year.

Funding sources increased by $75 million to match the capital allocation activity in the quarter. One last item before we go to Q&A. You probably noticed that we published a revised supplemental reporting package and updated investor presentation last night. We are pleased to provide cleaner, simpler disclosure going forward in our supp on the total portfolio while also maintaining key information and performance metrics that we have previously provided. The materials commence with our portfolio-level information across top markets and tenants followed by our same-store redevelopment and ancillary financial information. To recap, we are very excited about our Q1 results and upside for the year.

Our core earnings growth model that Pete described is working across the board, and absent the dilution from our 2025 dispositions, we are already delivering mid-single-digit growth. We, therefore, remain confident and laser-focused as we target the upper end of our revised FFO per share and same-store NOI guidance. With that, operator, let’s open up the call for Q&A.

Operator: Our first question comes from the line of John Kilichowski with Wells Fargo.

William John Kilichowski: Maybe first, if we could just start with the same-store guide we appreciate the bump here, but the 6.9% certainly stands out in 1Q. How do we think about that conservatism there? What drove the 6.9%? Was it comps? Was it just a great quarter? And is there an ability to repeat something a little bit closer to that going forward?

Peter Scott: John, it’s Pete here. I think as you pointed out, we had a great first quarter, posting same-store of nearly 7%. And the main pieces of that were we did see a pretty significant ramp-up in occupancy year-over-year and also some margin improvements. And that’s something, if you go all the way back to our strategic deck, we said those were 2 important metrics that we wanted to improve, and we have. And we also had some strong leasing in the first quarter. I think to your comments about deceleration implied in our same-store guidance, and I think you touched on this just a bit in your note last night, I don’t really think about it necessarily as deceleration.

I mean I think about it as an opportunity to raise guidance a few more times as the year progresses. So I like to look at it as the glass is half-full, not necessarily the glass is half-empty. I will say we had an easier comp in the first quarter. I think that was pretty well known. If you looked at our results last quarter — or excuse me, last year, we had a tough first quarter and it ramped up significantly in quarters 2 through 4. I still expect our growth to be quite strong and much longer than historical norms for the balance of the year.

But we might not see something all the way at that like near 7% level, but I would expect it to continue to be strong.

William John Kilichowski: Got it. That’s very helpful. And then the second one, Pete, you gave some very helpful color in the opening remarks on the capital allocation opportunities and the buyback and doing what’s best. I’m curious how you feel about the push and pull of doing what’s most accretive but also managing leverage. You put a ton of effort into getting the balance sheet into a good place. And now you’ve kind of done that, you take up leverage ever so slightly, like it’s still in a good spot.

But what’s that point at which you’re like, okay, the buyback is now off the table, we can’t lever up past this and the incremental proceeds need to go towards, like you said, the JVs or the redev versus that?

Peter Scott: Yes. It’s a good question and I’m glad you brought it up because I did want to spend a lot of time on it in the prepared remarks and on this call. In the first quarter, we did all 3. I think it was a nice mix of buyback, we did a JV acquisition, and we allocated capital to redevelopments. All 3 are accretive to our earnings growth. So we’re pleased about that, especially since we can utilize balance sheet capacity for it. So I think it’s the right mix to continue to focus on all 3. I will highlight the word disciplined, right?

I have seen, and I’ll again repeat the O word pop up from time to time, and I would not characterize it as that. I would characterize this as a very, very disciplined capital allocation approach. And to your point about leverage, I would also point out that we will not shy away from selling more assets, including core assets, right? So not selling lower quality. That was a lot of what we did last year to get the portfolio to where we wanted it to be today. Our focus could be on selling more core assets and accretively recycling that back into the 3 priorities.

We just think it’s good to have a good mix of different options available to us, and we think it’s the right mix right now.

Operator: Your next question comes from the line of Nick Yulico with Scotiabank.

Nicholas Yulico: I wanted to first ask on total occupancy. I know you have that 92% to 93% target. You said you’re at 90.5% in the first quarter. I think sort of twofold here, one is just latest thoughts on sort of the time frame for achieving that target. And then I think a component of that is leasing up development, redevelopment, where there is just some pure vacancy today. And I think, Rob, you gave some stats on like a Sign Not Occupied pipeline, but I’m wondering if you had any of that time Signed Not Occupied specifically you could cite for that development/redevelopment pool?

Peter Scott: Yes. Nick, it’s Pete here. I’ll start and maybe I’ll have Rob jump in on the backside. We do see redevelopments as a great way to invest capital and get a nice cash-on-cash return. It’s the 10% cash-on-cash return that we are targeting on average. And as we think about that portfolio, we did improve our disclosures a couple of quarters ago to track the percent pre-leased within that bucket. That’s actually where a lot of our SNO sits right now. So our 90.5% of occupancy today does not get the benefit of a lot of that pre-leasing that we’ve been able to do in the redevelopments. But we will continue to disclose that.

And as you saw, there’s 900 basis points effectively of sequential occupancy gains within that — or I’d say leased gains within that portfolio. It hasn’t turned into occupancy yet. So I don’t know, Rob, if you want to give any more color behind that.

Robert Hull: Yes, I’ll just add to that, this is a substantial — in our SNO pipeline, 90,000 square feet, nearly half of that in that kind of lease-up redevelopment bucket. So a substantial amount, which is where we see a lot of the opportunity to drive occupancy over the course of this year. I would also say that our pipeline remains strong at the 1.4 million square feet. That’s a good leading indicator of where we’re headed. Tenant retention is still a major source of occupancy gains. And we expect all 3 of those to contribute meaningfully this year.

Nicholas Yulico: Okay. Great. That’s really helpful, guys. Second question. Pete, I want to go back to the commentary about you’re open to selling core assets. And I guess — and then also going back to your point about earnings growth and that being a focus. Is this an opportunity — is this more than just a sort of opportunity to sell at a strong cap rate and sort of arbitrage that on the investing side, which is maybe like a onetime earnings benefit?

Or are you also open to selling core assets because in some ways you’re going to get a low cap rate and they’re also structurally slower growth assets for every reason, maybe they’re safer profile of the lease, whatever it is, that if you’re actually selling core assets, you could be improving sort of a long-term growth profile?

Peter Scott: Yes. I would go back to my comment in the prepared remarks about 5% of our portfolio, the NOI being in joint ventures right now. And we get some pretty nice advantageous fees. So any going-in cap rate for like a core-plus asset is an enhanced yield to us with regards to our initial cash yield. I think that’s one of the beauties of JVs and that’s why a lot of REITs employ JVs as an important part of their business model. I think 5% is low. I think 5% could grow. I won’t give a number as to where it could grow, but I think it could grow well beyond 5%.

And I think I’ll look at selling core assets and recycling that capital back into potentially JVs as a use of proceeds could be done accretively and I think would be a good thing for our portfolio as well as for shareholders.

Operator: Your next question comes from the line of Seth Bergey with Citi.

Seth Bergey: Just want to kind of go back to the JV comments. How are partners thinking about how many partners are you kind of in discussions with that are interested in investing in outpatient medical? And can you just talk about kind of the overall depth of the transaction market and interest in the outpatient medical space?

Peter Scott: Yes. Maybe I’ll start with that and Ryan can talk briefly about the transaction market. As you think about our JV exposures, we do have a few different JVs, but there’s really just one at the moment that is what I would call more a growth JV. And that’s with our partner at KKR that was set up a couple of years ago. There was a pool of assets that was contributed by the company into that joint venture. But the hope was that, that joint venture would grow over time by acquiring third-party assets or, I’d say, external growth. It’s another good way to characterize that.

Nothing happened over the last couple of years, really because there was no capital or balance sheet capacity here for any desire at Healthcare Realty to grow, even though our partner had a desire to grow. So I would say what we’re focused on right now is growing with that 1 partner. I don’t know that I want to get into any additional JVs that we could potentially look to set up over time. The other JVs that we do have, they’re more discrete assets. Those were set up many years ago prior to that KKR joint venture, and I would not look at those necessarily as growth ventures.

Our growth is really going to be focused with that 1 partner right now. And then Ryan, do you want to talk about the transaction market briefly?

Ryan Crowley: Sure, Pete. I’ll say that the momentum that built from the transaction market last year has certainly carried into 2026. If anything, the strength of that private bid has only increased and financing remains really available. There’s plenty of demand and liquidity out there. If you want me to talk about cap rates, I’d say that core assets are pricing today in the 5.5% to 6% range. And frankly, core-plus isn’t much above those levels.

Seth Bergey: Great. And then just coming back to some of the — your opening comments about retention and escalators. Just given that occupancy for outpatient medical is kind of in that low 90s places, where do you think those metrics could ultimately go in terms of just new lease economics?

Peter Scott: Yes. Good question, Seth. I mean what I would say is we completely revamped our approach to leasing about the middle of last year and we’ve become just much more financially rigorous as we underwrite deals. And I think what you’re starting to see is the benefits of that change is starting to work its way into both the amount of leases we’re getting done as well as the output of those. So retention, as you point out, at 93.5% is really strong. We did get the benefit of doing a couple of very, very large leases in our single tenant bucket that were pushed out quite a way.

So if you look at our weighted average lease term, it actually almost went up about a year this quarter, which is a pretty big change in 1 quarter. I would say from a retention perspective, I don’t know that I would model 93.5% going forward. But if it used to be 75% to 80%, I’d like to think that it could be more like 80% to 85% going forward. And then on the cash leasing spreads, we did put up a good quarter this quarter. It was over 4%. I’ll point out 1 out of every 4 lease deals that we did was greater than 5%.

And we are focusing heavily on that, to try and push as much as we can on that metric. I’d like to think it can even improve upon 4%, but this will take perhaps a little bit of time to continue to work into the system. But we are optimistic and we’ll continue pushing.

Operator: Your next question comes from the line of Michael Carroll with RBC Capital Markets.

Michael Carroll: Pete, I wanted to circle back on those early renewals that you’re able to execute during the quarter. I mean what drove those decisions? Is that something that you approached the tenant about? Or did they approach you about it? And given that those assets now have much longer term, is that something that you sell now or could potentially sell just given that you have about 10 years on some of those leases?

Peter Scott: Yes. I mean we certainly could. I don’t know that I can go into each one of those. It would take too long on this call to go through all the different assets within that bucket. But certainly, if it’s a single tenant expiration and it’s got less term on it, I mean you guys can go talk to the folks in the triple-net world, but when there’s not a lot of term on a single-tenant asset, it’s really not worth anything. So we’ve certainly unlocked some value in extending those. But I won’t really comment at the moment on what our lands are for those in particular.

I will say extending the weighted average lease term was actually quite important. We got a question on that a couple of quarters ago. And I felt confident we were going to do it. I would say many of these discussions on those lease deals took multiple quarters to get done. So I think you’re seeing multiple quarters of work in our results that we put out in the first quarter.

Robert Hull: I would just add to that, Pete, that, to your question about the systems approach us, in some cases, they did. And I would say that it’s kind of an indication of the environment that we’re in. Vacancy is getting lower. It’s more expensive to build new products. And so we’re seeing an uptick in discussions with health systems, and I think that’s where you’re seeing us able to drive lease economics.

Michael Carroll: That’s helpful. And then on the investment side, I know [ like in prior calls ], I mean there’s been a lot of discussions on how attractive some of those opportunities are, it does look like, given the stuff that you’ve done year-to-date, you’re kind of approaching the top end of the guidance range provided. I mean how do we kind of compare those 2? So you’re seeing good opportunities, but it’s not reflected in guidance. Is that just you trying to be cautious, not wanting to over-extend yourself without having some type of source of funds coming in? Or how do we explain those 2 differences?

Peter Scott: Yes. I mean one thing and then I’ll turn it to Dan. I mean, look, Mike, it is early in the year. Obviously, we put up some good results and we’re able to raise guidance in the first quarter. So I feel quite pleased with that. But there’s more quarters to go, more for us to do, and I think there’s more upside for us to go capture as well as we execute with purpose. But maybe I’ll have Dan talk about balance sheet capacity.

Daniel Gabbay: Yes. And Mike, as we started talking about at the beginning of the year, we have balance sheet capacity. We’ve always talked about having upwards of $100 million to $200 million, sort of in that range, of balance sheet capacity as we entered the year. We’ve used some of that. We continue to have capacity. And as Pete mentioned, we have the ability, if there’s the right assets to sell and harvest at great valuations, we can recycle more capital into external growth.

As it relates to our guidance specifically, we’re taking the approach with guidance that what you see in sources and uses is what we’ve announced to date and we don’t include any future acquisitions or share repurchases in our guidance going forward. And we’ve given folks our outlook on — for the year of dispositions as well, which is tracking nicely. And we’re already including this $45 million loan repayment we talked about in our press release being repaid, actually it’s this week. And so we are halfway on our dispositions already towards the midpoint of our target. So feeling good about those sources and uses.

And as we have more activity, we’ll continue to update those ranges and update you and the market as those transpire.

Operator: Your next question comes from the line of Michael Goldsmith with UBS.

Michael Goldsmith: I’m here with Justin Haasbeek. Maybe first, your same-store occupancy was up 110 basis points to 92.3% in the quarter. So really the question is how high can occupancy go in the same-store portfolio? Or maybe asked another way, how should we think about frictional vacancy for your portfolio in outpatient medical?

Peter Scott: Yes. Michael, it’s Pete. And thanks for picking up coverage. We appreciate it. I mean, look, we’re in the low 92% area. If you go back to our strategy deck, we said we’d like to get to 92% to 93%. I think as we’ve improved our portfolio, I’d like to think we can get closer to the 93%. We’ve said actually that we believe there is some absorption as the year progresses as well, which is a positive for us, and that certainly will help our same-store. As to your question around just like frictional vacancy, I mean, I think that’s probably about right, like mid to high single digits.

I mean we just don’t have a very, very large triple-net, single-tenant portfolio, which typically when you see other REITs that own assets like we do, will have higher occupancy levels because of that. We have a big multi-tenant portfolio, which is actually, we think, a positive in an environment where you’ve got more demand and less supply right now. So I think you’ll always have a little bit of vacancy as doctors retire and things like that. But I feel like we’re getting close to it.

We’re very focused on getting the total occupancy in the portfolio, the 90.5%, I mean getting that up to 92% to 93%, I mean that’s going to be the big opportunity for us as we think about exceeding our 3-year forecast over the next few years.

Michael Goldsmith: Got it. And then just as a follow-up, when you annualize your first quarter normalized FFO, you get pretty close to the high end of the guidance range. So just wondering if there’s some conservatism baked in or another drag outside of the August debt maturity that we should be aware of? Or just how we should think about it?

Peter Scott: I think you’re thinking about it the right way. The only drag, I would point out is what’s going to happen with that bond that does come due in August. But we did put out that delayed draw term loan, the announcement on that. So I feel like we’ve been able to significantly derisk that. And frankly, we’ve got plenty of runway now with that term loan where — I’m a big believer in the capital markets. You can never time them perfectly, but you can certainly access those markets at times when you can become a price maker and not a price taker.

I felt like we were in the price taker bucket without putting that term loan in place. And with that bullet maturity coming up in August, and with the dislocation in the markets the last couple of weeks, we pivoted very, very quickly. And I credit Dan and his team for putting that together and I thank our banking partners for that. Because I think the all-in cost on that is in the mid-4s. When you compare that to bond pricing today, we’d probably be 50 to 75 basis points wider. So that’s a really good financing for us to put in place.

Operator: Your next question comes from the line of Austin Wurschmidt with KeyBanc Capital Markets.

Austin Wurschmidt: Pete, I appreciate you highlighting some of the various items that you’re targeting to improve the growth profile and just returns associated with medical office. If 2% to 3% internal growth doesn’t cut it for the reasons you highlighted, I guess, what’s the right growth level you think is achievable? And just the time line it takes to reset that internal growth based on the lease maturity schedule.

Peter Scott: Yes. Good question. I mean yes, I agree, 2% to 3% NOI growth just, as much as I’d like to say it works, it just won’t work anymore. So I don’t know that 7% is the right number for us to anchor ourselves to right now, for the reasons I mentioned in a question before. But probably something right in between. And then I will go back and focus you on a comment I said in my prepared remarks. And I get this is us working around some magic numbers behind the scenes.

But if you back out the dilution from the portfolio optimization and the deleveraging from last year and you look at our actual organic growth this year, it’s actually above 5%. So I’d probably start anchoring around a number like that. I mean obviously, we have other things we have to factor in as well with regards to our balance sheet and our refinancings over the next couple of years. But I think from a pure organic growth perspective, that’s probably the best number I can anchor you to.

Austin Wurschmidt: That’s helpful. And then switching gears, Ryan or Pete, as a follow-up to some comments earlier, you flagged the cap rates are in the 5.5%, 6% range for core assets, core-plus isn’t much above that. I mean is that what we should be thinking about on future dispositions? And what gives you the confidence then that you can source deals at going-in yields in excess of 7%? And I think you said in the prepared remarks, especially if these are lease-up opportunities with higher growth potential.

Peter Scott: Yes. Well, I’d point you to the deal we just did in Birmingham. It’s a $90 million deal, a core asset, 100% occupied, newly developed, 12-year weighted average lease term. The going-in cap rate on that was a 6% and our going-in yield was in the low 7s from a cash perspective. I’d say from a GAAP perspective, which we don’t really talk about a lot, you’re actually north of an 8% on that. So as we think about stock buybacks and the FFO yield versus putting capital to work in investments, we do have to look at GAAP yields from time to time.

So that’s a core-plus asset that we feel quite good about the accretion on that because the going-in yield is actually wider than or above our implied cap rate, and that’s an important metric that we would look at. I’d say if we were looking to sell core assets, I would expect to be getting pricing even inside of that. That would be our take. Not every asset we’re going to sell is going to be core. I think we will look to do just some typical core-plus pruning as well.

But to the extent we looked at selling core assets, and we’ve got a lot of them, I would expect us to do quite well if we decided to transact.

Operator: Your next question comes from the line of Rich Anderson with Cantor Fitzgerald.

Richard Anderson: So perhaps a cynical question first. You said at the top, and you just kind of got — went through the growth number, Steady Eddie growth isn’t going to cut it in this market, and you’re saying maybe somewhere between 3% and 7% will cut it. I recognize you can’t be very precise there. I wonder if that will sway the conversation around the growth profile of MOBs, we’ll see. But I guess the question I have is if you’re solving for a growth level and then sort of work backwards to achieve it, there have been dangers in the past of people doing unnatural things to sort of break the status quo.

So how do you avoid sort of the complications around that? How do you avoid sort of losing reputational capital if the rest of the MOB market isn’t sort of buying into this new paradigm shift? I’m just curious how do you manage all of those sort of moving parts as you reassess the growth of the business.

Peter Scott: Rich, good question, and thanks for your cynicism. But let me just spend a second on the value creation opportunity and maybe expand on my premium multiple comments that were in the prepared remarks. If you think about our current valuation, in my opinion, that implies basically minimal to no growth going forward, right? I mean I’m biased, I think it’s way too low. But I think it implies very, very, very little growth when you look at how we stack up within the entire REIT industry. And I think it’s very much backwards-looking.

But I respect that, that’s where we are right now, and we’re still only a year into putting out our — less than a year to putting out our strategic plan. So as I said, we have a challenge in front of us. One, we have to put up better numbers. I think this quarter, and actually if you look at the last couple of quarters, they’ve been much better than they’ve been historically. And we obviously have to redefine what we think success is in our sector. I would say success for us is not going from an 11x FFO multiple to a 30x FFO multiple.

I mean I tip my cap to those companies that trade at those stratospheric levels, and then they’re doing a fantastic job keeping the market excited and it’s great for them. Success for us is not going all the way to those stratospheric levels. It is taking our multiple from 11x to something commensurate with where I think other similar growth characteristics or other REIT sectors that grow at a similar level to where we can grow are. And they’re not at 11x. They are better than 11x. I think they are about 3 to 4 turns better than where we trade right now.

I’ll let you guys do the math, but that’s pretty significant value creation from where we trade today. So I’m not looking to all of a sudden persuade everybody and say, oh my God, these guys are now going to grow at such an amazing level that they deserve this stratospheric level type multiple. We’re very, very much rooted in realism here and what we think the right total return profile is. But it’s a lot better, we think, from an earnings growth perspective than the old Steady Eddie model.

Richard Anderson: Okay. Perfectly fair. And second question, on selling core assets, I know it’s a little bit of a conversation piece today. What governors do you have on yourself to limit how much of that you’re willing to do? Because you don’t want to be guilty of throwing the baby out with the bath water. I recognize that there is sort of an accretive transfer of capital. But you — someone just brought up core numbers — core cap rates for core assets, I should say, are 5.5% to 6%, and not so core are just a little bit above that. So I just wonder what the real risk-reward benefit is of being overly aggressive with the core to asset sales.

Peter Scott: Yes. I will go back to the word disciplined, Rich, like we’re going to be disciplined, and I said we are open to selling core assets and recycling that capital accretively. And if you go back and take a look at all the numbers I’ve been discussing in here, they are all very modest type figures. So I would not look at this as we’re just going and liquidating the highest-quality stuff. And you know this even better than we do, there’s a limit from a tax gain capacity from how much we can do as well.

But I think in moderation, we will certainly look to dispose of or potentially contribute some core assets into ventures as well where we still retain a stake in those. So like I said, we’re looking at all options. I know we get questions on balance sheet capacity and our ability to recycle capital into our capital allocation priorities. And I felt like just pointing out we’re not just going to utilize the balance sheet for this and lever up. We will certainly look at taking advantage of our portfolio to allow us to continue to further that.

Operator: Our next question comes from the line of Daniella de Armas Rosales from JPMorgan.

Daniella de Armas Rosales: Your spreads in the quarter were strong with 4% average. But can you give us some color on the 13% of renewals that had negative spreads? And do you think those roll-downs are largely behind you?

Peter Scott: Yes. We tend to focus on the blended number of over 4% and actually achieving a lot higher on the upside. I would say that selectively, if we feel like, and I would go back to my comment earlier, if we feel like the better play for us is to retain a tenant as opposed to seeing them walk from a building, we will add time selectively look at modest roll-downs because we will look at the whole financial package as we look at this. What’s it going to cost to re-lease that? What’s the downtime? What’s the CapEx? So I don’t know that I would say, going forward, we’re always going to have every lease 5% or above.

We’ll certainly strive to do something like that. But at times, we may selectively make a decision to allow a tenant to stay for a variety of reasons. But at the end of the day, we would make that decision because the IRR for that lease is much better than the alternative.

Operator: Your next question comes from the line of Michael Stroyeck with Green Street.

Michael Stroyeck: Maybe going back to same-store NOI growth, are there any known tenant move-outs or any other moving pieces that you expect to weigh on NOI growth during the rest of the year outside of just tougher year-over-year comps?

Peter Scott: No. I mean if I look at the remaining lease expiration for 2026, I mean, that number, if you go back and look last quarter versus this quarter, has come down significantly. I gave you some thoughts on retention before in the 80% to 85% area. I’d expect the remaining lease expirations for this year to kind of track within that range. We’ll retain the vast, vast majority of those tenants. So there’s nothing that jumps out to me. I would just point out that we had a bit of an easier comp this quarter that we won’t have in the next couple of quarters. But I would still look at the blended midpoint of 4.25% today.

And as we’ve said, we think there is probably a little bit of upside as the year progresses on that, or at least that’s what we would hope if we execute. And that’s still really strong growth. So I would focus — while we are focusing on the strong number this quarter, 1 quarter you got to average out over the entire year. But I think for the year, it’s still quite strong growth relative to historical norms.

Michael Stroyeck: Got it. That’s helpful. And then maybe following up on an earlier acquisition yield discussion. You outlined the 6% yield going to 7% on that recent Alabama deal. So just clarifying, is that 7%-plus yields that you’re underwriting, is that more of a stabilized yield or is that actually expected year 1 you expect to see?

Peter Scott: That’s year 1. That’s not a stabilized yield. That’s what we’re going in at.

Robert Hull: Mike, I’d just point out that when we talk about the JVs, that’s inclusive of the advantageous fee arrangements that we have with our partners, that we’ve talked about so far this year.

Operator: Your final question comes from the line of Juan Sanabria with BMO Capital Markets.

Robin Haneland: This is Robin Haneland sitting in for Juan. Just curious on the strategic 3-year plan, if there’s any updates compared to initial expectations, and whether you could share with us the next low-hanging fruits?

Peter Scott: Yes. Look, I think what I would say on that is that we’re tracking ahead of schedule at this point in time. And frankly, we’re 1 quarter into a 12-quarter forecast. And to be tracking ahead of schedule, I think, is a testament to the hard work that the entire organization has put into preparing for kicking off this 3-year forecast, and also for the financial rigor that we’re improving in this organization. I hate to continue to repeat that word, but I think if you guys were in here every day, you would see it and be quite impressed.

The other thing I would just point out with regards to this year, I mean, this year was expected to be a flat year from an FFO perspective. And I think 1 quarter into the year and we’re already exceeding from that perspective, and we’d like to continue to have an opportunity if we execute to increase guidance for the balance of the year as we go along. Obviously, we have to continue to execute with the intensity that we have been. So as I would say, I feel like we’re tracking ahead of schedule.

Not ready to say much more than that at this point in time being 1 quarter in, but it’s good to be saying that at least that early on.

Robin Haneland: And I was just also curious on if there are any signs of supply picking up and I’d be curious to know how far rents are off from being able to pencil.

Peter Scott: I want to talk about supply, Ryan, because it really hasn’t picked up?

Ryan Crowley: We’ve seen new completions drop in recent quarters and new starts have remained fairly flat. They’re actually tracking well below historical industry average of, call it, 1.5% to 2%, in what is a 1% of inventory range. So no, not much on that front. .

Operator: And with no further questions in queue, I will now turn the call back over to the company for closing remarks.

Peter Scott: Great. Well, thanks, everyone, for joining the call. We have a couple of industry conferences coming up later this month. We look forward to seeing you there. And then if we don’t see you there, we’ll see you at NAREIT. Thanks very much.

Operator: Thank you again for joining us today. This does conclude today’s presentation. You may now disconnect.